Menu
17/12/2012
Call For Epilepsy Medications To Be Excluded From Generic Substitution
Speaking in the Dáil today during the Second Stage Debate on the Health (Pricing and Supply of Medical Goods) Bill 2012, Meath East TD and member of the Oireachtas Health Committee, Regina Doherty, called for epilepsy medications to be excluded from generic substitution.
Deputy Doherty is supporting the amendment to the Bill being proposed by Brainwave, the Irish Epilepsy Association.
He said: "This legislation is one of a number of Government initiatives aimed at driving down the State’s medicines costs. A three year deal with the Irish Pharmaceutical Healthcare Association will deliver up to €400 million in savings. Generic substitution and reference pricing is expected to deliver a further €50 million in savings, by allowing pharmacists to prescribe cheaper generic drugs instead of more expensive branded medicines.
"Reform and innovation in healthcare and the pharmaceutical industry is very welcome. However, we must consider how these changes can affect the needs of patients with particular conditions. Epilepsy is one such condition that is simply not compatible with generic substitution.
"Professor Norman Delanty, Director of the Epilepsy Programme in Beaumont Hospital, has said that anti-epilepsy medications can’t be substituted with generic drugs without having a profound effect on the well-being of the patient. Doses of epilepsy medications are concentrated carefully for each individual patient, to ensure good control of seizures. Any variation to the dosage could disturb the balance and result in an otherwise avoidable seizure, even if the active ingredient of the drug is not changed.
"In my view, the treatment of epilepsy is too delicate a science to include in generic substitution. The push to exclude anti-epilepsy drugs from this Bill is supported by the entire epilepsy community and the healthcare professionals that treat them. Many other countries, including the UK, Austria, Belgium and the Czech Republic do not allow for the generic substitution of epilepsy drugs."
(CD)
Deputy Doherty is supporting the amendment to the Bill being proposed by Brainwave, the Irish Epilepsy Association.
He said: "This legislation is one of a number of Government initiatives aimed at driving down the State’s medicines costs. A three year deal with the Irish Pharmaceutical Healthcare Association will deliver up to €400 million in savings. Generic substitution and reference pricing is expected to deliver a further €50 million in savings, by allowing pharmacists to prescribe cheaper generic drugs instead of more expensive branded medicines.
"Reform and innovation in healthcare and the pharmaceutical industry is very welcome. However, we must consider how these changes can affect the needs of patients with particular conditions. Epilepsy is one such condition that is simply not compatible with generic substitution.
"Professor Norman Delanty, Director of the Epilepsy Programme in Beaumont Hospital, has said that anti-epilepsy medications can’t be substituted with generic drugs without having a profound effect on the well-being of the patient. Doses of epilepsy medications are concentrated carefully for each individual patient, to ensure good control of seizures. Any variation to the dosage could disturb the balance and result in an otherwise avoidable seizure, even if the active ingredient of the drug is not changed.
"In my view, the treatment of epilepsy is too delicate a science to include in generic substitution. The push to exclude anti-epilepsy drugs from this Bill is supported by the entire epilepsy community and the healthcare professionals that treat them. Many other countries, including the UK, Austria, Belgium and the Czech Republic do not allow for the generic substitution of epilepsy drugs."
(CD)
Related Irish News Stories
Click here for the latest headlines.
11 February 2013
1 In 5 People Would Not Employ People With Epilepsy
On European Epilepsy Day today, Epilepsy Ireland released results of national consumer research conducted in January 2013 which show that nearly 20% of people if given the choice would not employ someone with epilepsy.
1 In 5 People Would Not Employ People With Epilepsy
On European Epilepsy Day today, Epilepsy Ireland released results of national consumer research conducted in January 2013 which show that nearly 20% of people if given the choice would not employ someone with epilepsy.
06 June 2013
New Legislation Obliges Chemists To Offer Generic Drugs
New legislation will see pharmacists made to offer patients the cheapest available version of a drug, in an effort to save millions from the States medical bill. Patients will be offered a cheaper generic version of a drug evenif a doctor has prescribed a brand name product, according to Irish Medicines Board Chief Executive Dr Pat O'Mahony.
New Legislation Obliges Chemists To Offer Generic Drugs
New legislation will see pharmacists made to offer patients the cheapest available version of a drug, in an effort to save millions from the States medical bill. Patients will be offered a cheaper generic version of a drug evenif a doctor has prescribed a brand name product, according to Irish Medicines Board Chief Executive Dr Pat O'Mahony.
06 August 2012
Patients And Taxpayers Being Ripped Off By Drug Prices
Commenting on the Sunday Business Post survey showing the high price of generic drugs in this State, Sinn Féin Health spokepserson Caoimhghín Ó Caoláin TD said it showed that patients and taxpayers are being ripped off. He said: "The survey shows that the HSE and patients here are paying up to 12 times more than the NHS for the same generic drugs.
Patients And Taxpayers Being Ripped Off By Drug Prices
Commenting on the Sunday Business Post survey showing the high price of generic drugs in this State, Sinn Féin Health spokepserson Caoimhghín Ó Caoláin TD said it showed that patients and taxpayers are being ripped off. He said: "The survey shows that the HSE and patients here are paying up to 12 times more than the NHS for the same generic drugs.
27 June 2013
High Pharmaceutical Prices Slammed
Labour Phil Prendergast MEP has announced her disappointment at the conclusions of the ESRI Report on Pharmaceutical Prices in Ireland. She said: "The price of pharmaceuticals in Ireland has always been a source of concern, but this is particularly the case when people are struggling with higher levels of personal debt.
High Pharmaceutical Prices Slammed
Labour Phil Prendergast MEP has announced her disappointment at the conclusions of the ESRI Report on Pharmaceutical Prices in Ireland. She said: "The price of pharmaceuticals in Ireland has always been a source of concern, but this is particularly the case when people are struggling with higher levels of personal debt.
30 July 2014
Epilepsy Seizure Drug Recall Ordered
Epilepsy medication is being recalled "as a precautionary measure", the Health Products Regulatory Authority (HPRA) has reported. Batches of Buccolam Oromucosal Solution, a prescription-only medication used to treat seizures, have been recalled by manufacturers ViroPharma SPRL.
Epilepsy Seizure Drug Recall Ordered
Epilepsy medication is being recalled "as a precautionary measure", the Health Products Regulatory Authority (HPRA) has reported. Batches of Buccolam Oromucosal Solution, a prescription-only medication used to treat seizures, have been recalled by manufacturers ViroPharma SPRL.
-
Ireland WeatherToday:Scattered sleet and snow showers will turn increasingly heavy and more frequent in the afternoon across the north. Largely dry with sunny spells in the south, but showers spreading here towards the end of the day. Maximum temperature 4 °C.Tonight:Frequent, often heavy showers of rain, sleet and snow will affect most parts this evening and overnight, but are likely to be most frequent across the northeast. Minimum temperature -1 °C.
